Reneo Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Reneo Pharmaceuticals, Inc.
CIK #0001637715
EDGAR Form CIK 2011 - 2026
10-K [0001637715]
10-Q [0001637715]
3 [0001637715]
4 [0001637715]
8-K [0001637715]
D [0001637715]
SC 13D [0001637715]
SC 13G [0001637715]
Form 13D/13G Filer Form 13D/13G Subject Filed
Biotechnology Value Fund L P Onkure Therapeutics Inc [2026-05-27]
AI Biotechnology LLC Onkure Therapeutics Inc [2026-04-07]
StepStone Group LP Onkure Therapeutics Inc [2026-04-07]
RA Capital Management LP Onkure Therapeutics Inc [2026-04-07]
Trails Edge Capital Partners LP Onkure Therapeutics Inc [2026-04-07]
Acorn BioVentures LP Onkure Therapeutics Inc [2026-04-01]
Adar1 Capital Management LLC Onkure Therapeutics Inc [2026-02-17]
ProSight Management LP Onkure Therapeutics Inc [2025-11-28]
Cantor Fitzgerald & Co Onkure Therapeutics Inc [2025-08-14]
Highbridge Capital Management LLC Onkure Therapeutics Inc [2025-08-14]
View All
Form 3/4/5 Subject 2011 - 2026
Saccomano Nicholas A
OnKure Therapeutics, Inc.
Leverone Jason A.
Jansen Valerie Malyvanh
Mathers Edward T
Carruthers R Michael
Ratcliffe Liam
Grey Michael G
Phillips Andrew John
Access Industries Management LLC
View All
Terms | Privacy | Providers | Guide
tony@aum13f.com